Innovation Pharmaceuticals Inc (IPIX)

[RJFL]

Hi 58nout - It's our guy. This is the description from the iogenetics page:

http://www.iogenetics.com/about_us/management.html#anchor4

Daniel Jorgensen, MD, MPH
Chief Medical Officer

Dr. Jorgensen is an accomplished physician executive and corporate officer with 16 years of Industry experience, including 10 years at Pfizer. Most recently, he was the Senior Vice President, Clinical Development and Chief Medical Officer at PolyMedix, Inc., where he successfully conducted the first clinical efficacy study on a novel class of immunomodulatory antimicrobial compounds known as defensin-mimetics. At Pfizer, Dr. Jorgensen was the Global Clinical Leader for Zmax (single-dose azithromycin) and the Development Team Leader for dalbavancin (second generation glycolipopeptide). He was named Pfizer’s first Vaccine Development Team Leader and was responsible for the company’s first human vaccine trial (DNA influenza vaccine). He began his Industry career at Pasteur Merieux Connaught, in the area of viral vaccine development. In these leadership roles, he has successfully ushered several products from early clinical development through full regulatory approval, both in the U.S. and abroad, playing a key role in NDA submissions and FDA Advisory Committee Meetings. Dr. Jorgensen is a CDC-trained epidemiologist (EIS Officer), with public health experience at all levels (local, state, national, international), and is the former Chief Medical Officer for the State of Montana. Dr. Jorgensen received his undergraduate degree from Yale, his MD from the University of Wisconsin, his MPH from the University of Washington, and his MBA from Yale. He is board-certified in three medical areas: pediatrics, infectious diseases, and preventive medicine.